Leadership Team
Mr Brad Dilkes | Non-Executive Director
Mr Brad Dilkes has more than 15 years’ experience working in the investment and corporate advisory sectors within the context of emerging companies.
He has been an Associate Director of boutique corporate advisory firm Alignment Capital for 8 years, providing corporate services to high-growth companies listed, or seeking to list, on the ASX. Prior to this role, he was an investment advisor at a micro-cap focused investment bank.
Brad has specific experience in project conception and deal origination in the biotechnology sector, founding a range of research and development projects and companies in emergent fields of study.
Mr David Hainsworth | Executive Chairman
Mr David Hainsworth is a finance professional with more than 20 years’ experience in capital markets.
Currently serving as Associate Director of Australian boutique corporate advisory firm Alignment Capital Pty Ltd, Mr. Hainsworth’s responsibilities are principally centred on the origination and execution of capital market transactions within high-growth sectors. Prior to this role, he was an investment advisor at Euroz Hartleys Ltd, a highly regarded and publicly listed wealth management company.
His significant expertise extends to corporate financing and capital raising, with a specialisation in early-stage projects in the biotechnology industry.
Mr Bradley Latham is an accomplished and energetic businessperson with strong commercial acumen and extensive business experience. The majority of Mr Latham’s working career has been with Sydney Markets where he has worked his way through the ranks until appointed CEO of the group in 2006.
Mr Latham has a proven track record of business leadership and has a strong understanding of good corporate governance and risk management. He possesses an ability to identify and assess strategic growth opportunities.
Mr Latham holds a Master of Management from the University of New South Wales.
Mr Bradley Latham | Non-Executive Director
Dr James McKenna | Chief Scientific Officer
Dr James McKenna has been a full-time research scientist for 23 years, with experience in academic science, commercial drug development and intellectual property generation.
Most recently, he held a leadership position at an ASX listed biotechnology company where he managed and was involved in teams to advance pre-clinical and clinical R&D programs for the purpose of achieving US Food and Drug Administration (FDA) registration.
Dr Mckenna holds a PhD in biochemistry and molecular biology from the University of Melbourne.
Ms Leah Pieris | Company Secretary
Ms Leah Pieris is a Chartered Company Secretary and a Fellow of the Governance Institute of Australia.
Ms Pieris is a member of Automic Group, which provides market leading, cloudbased share registry technology, compliance and governance solutions, supported by a tailored range of professional services.
As a member of Automic Group’s Company Secretary team, Ms Pieris assists ASX listed companies across a range of industries.